A groundbreaking blood test for colorectal cancer screening could reshape early detection. Learn how this FDA-approved method ...
Last year's first quarter saw a flurry of biotech takeover deals, starting off with Johnson & Johnson (JNJ)/Ambrx, Merck (MRK)/Harpoon, GSK (GSK)/Aiolos and Novartis(NVS)/Calypso in early January.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback